CEL-SCI Corp. (CVM) Starts Presentation at 9th Annual LD Micro Invitational
CEL-SCI (NYSE: CVM) is a biotechnology company involved in the research and development of immunotherapy products for the treatment of cancer, autoimmune and infectious diseases. The company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances. CEL-SCI's vision is to change the way cancer is treated by developing novel immune-based therapies with potential to utilize the body's own immune defense system against the disease. CEL-SCI's lead investigational therapy, Multikine (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response. For…







